Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urethral Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Doxorubicin 7Ifosfamide 6brostallicin 2Trabectedin 2Filgrastim 2perifosine 1pegfilgrastim 1lorvotuzumab mertansine 1indolepropanol phosphate 1exatecan 1X-Rays 1Watchful Waiting 1Radiotherapy, Conformal 1Radiotherapy 1Observation 1Mass Spectrometry 1Imatinib Mesylate 1Gefitinib 1Combined Modality Therapy 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1Biopsy 1BI 2536 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Synovial × Gefitinib × Clear all
NCT00052754 2012-09-24

Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
48 enrolled
Sarcoma

Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡